Find uplifting stories about heroes, innovations, and solutions
525 results for "cancer treatment"
A tablet that makes cancer cells visible to the immune system shrank tumors by at least 30% in patients who had run out of treatment options. The breakthrough could help the two-thirds of cancer patients for whom immunotherapy currently fails.
A groundbreaking therapy that teaches the body's immune system to recognize hidden cancer cells has shown encouraging results in early human trials. The treatment helped one in five patients with hard-to-treat cancers, offering new hope where other options had failed.
A breakthrough cancer treatment helped patients with advanced lung cancer live over four months longer than current therapies. The experimental drug reduced the risk of death by 34% in a study of 532 patients.
A breakthrough drug targeting previously "undruggable" KRAS mutations has approximately doubled survival time for metastatic pancreatic cancer patients compared to chemotherapy. The development marks a historic shift for a disease that affects over 90% of pancreatic cancer cases. --- ##
A unique collaboration between researchers and doctors in San Antonio is cutting the time it takes to turn laboratory discoveries into real cancer treatments. Patients now have access to 500+ clinical trials testing therapies that began in local labs.
UCLA researchers discovered a targeted therapy drug that dramatically reduces the risk of lung cancer returning in patients with a rare genetic subtype. After two years, 92% of patients receiving the treatment remained cancer-free, compared to just 61% who received a placebo.
A revolutionary drug just doubled survival time for patients with advanced pancreatic cancer, one of the deadliest forms of the disease. Doctors are calling it unprecedented, and the breakthrough could soon help patients with lung, colorectal, and other cancers too.
A groundbreaking cancer treatment just gave patients with hard-to-treat lung cancer something they desperately needed: hope. Chinese biotech company Akeso's new drug ivonescimab beat the current standard treatment in a major clinical trial, marking a historic win for patients with limited options.
Women with advanced breast cancer now have a powerful new treatment option that postpones the need for chemotherapy. The combination of giredestrant and Afinitor offers hope for patients seeking gentler alternatives to traditional cancer treatment.
Men with high-risk prostate cancer now have a promising third treatment option that combines surgery with dual hormone therapy. A major clinical trial shows this approach works better than current surgical treatments, offering new hope to thousands of patients.
A breakthrough treatment for pancreatic cancer shows promise in doubling how long patients survive with one of the deadliest forms of cancer. This medical advance offers new hope for thousands of families facing this devastating diagnosis.
An experimental pill called daraxonrasib helped pancreatic cancer patients live nearly twice as long as those on standard chemotherapy. The breakthrough results, presented at a major cancer conference, mark a historic first for one of medicine's toughest cancers.
Men with high-risk prostate cancer now have a promising third treatment option that could save more lives. A major clinical trial shows combining hormone therapy with surgery significantly improves outcomes for patients who prefer surgery over radiation.
A breakthrough drug called daraxonrasib doubled survival time for pancreatic cancer patients compared to chemotherapy, offering new hope for one of the deadliest cancers. The treatment targets the genetic mutation behind 90% of pancreatic cancers and causes far fewer severe side effects.
Researchers in India discovered that an ultra-low dose of an expensive cancer immunotherapy works just as well as standard treatment at a fraction of the cost. The breakthrough could help millions access life-saving care while potentially reducing costs worldwide.
A targeted therapy called selpercatinib dramatically reduces the chance of early-stage lung cancer returning in patients with a rare genetic subtype. After two years, 92% of patients who received the drug remained cancer-free compared to just 61% who got a placebo.
A groundbreaking cancer treatment just showed remarkable results that exceeded doctors' expectations in treating one of the deadliest forms of lung cancer. The drug ivonescimab reduced the risk of death by 34% compared to standard treatment for patients with squamous non-small cell lung cancer.
A new cancer injection completely eliminated tumors in 15 patients who had run out of treatment options after their head and neck cancers returned. The five-minute jab also shrank tumors in more than a third of the 102 patients tested, offering new hope for thousands facing similar diagnoses each year.
A targeted therapy for advanced gastrointestinal cancer shrank tumors by 30% or more in 61% of patients who tried it as their first treatment. The breakthrough could offer hope to those facing drug resistance in a cancer that affects thousands worldwide.
A breakthrough cancer treatment delivered as a simple injection wiped out entire tumors in patients who had run out of options. For those with advanced head and neck cancer that stopped responding to chemotherapy and immunotherapy, this drug brought hope where none existed.
Showing 20 of 525